News
Stay up to date on topics that are important to Nurse Practitioners.
-
FDA Approves Three-Antigen Hepatitis B Vaccine
The FDA approved a new hepatitis B vaccine [recombinant]) (PreHevbrio) for the prevention of infection caused by all…
-
First Liquid Topiramate Formulation Approved for Seizure Indication
The FDA has approved the first ready-to-use liquid formulation of topiramate (Eprontia oral solution) for partial-onset, primary generalized…
-
Younger Patients Now Indicated for Asthma Drug
The FDA expanded the approved indications for dupilumab (Dupixent) injection to include add-on maintenance treatment of patients 6…
-
In a First, FDA Allows Marketing of Three New ENDS E-Cigarette Products
The FDA authorized the marketing of three new tobacco products, the first set of electronic nicotine delivery system…
-
Mirena IUD Now Approved for Pregnancy Prevention Up to 7 Years
The Mirena levonorgestrel-releasing intrauterine device was approved by the FDA for up to 7 years of pregnancy prevention.…
-
FDA Approves Treatment of Severe Hypoglycemia That Does Not Need Reconstitution
The FDA approved Gvoke Kit for the treatment of hypoglycemia in pediatric and adult patients with diabetes 2…
Trending
-
FDA Approved Semaglutide Injection to Reduce Risk of Serious Heart Problems in Overweight Adults
-
The Role of Pharmacogenomics in Precision Mental Healthcare
-
OTC COVID-19 Diagnostic Tests May Have an Extended Shelf Life
-
AANP Offers Resources to Help NPs Detect and Treat Ulcerative Colitis
-
Multistate Outbreak of Salmonella Linked to Cucumbers
-
5 Key Benefits of Getting a Second Certification as a Nurse Practitioner
-
8 Key Tips for Effective Communication During Pediatric ENT Exams
-
Normalizing Anxiety: How NPs Can Guide Patients to Make Healthier Choices
-
CDC Endorses Lowering Pneumococcal Vaccination Age from 65 to 50
-
FDA Proposes Ban on Over-the-Counter Oral Nasal Congestion Medication
-
Using Technology to Combat Drug-Drug Interactions
-
Building a Strong Professional Nursing Network as a New Nurse Practitioner
Join our email list
Get new course alerts, newsletters and more delivered directly to your inbox
By providing my personal information, including phone number, I consent to (1) receive email messages with information and offers, autodialed calls, texts, and prerecorded messages from FHEA, including current and possible future services, customer service and billing; and (2) FHEA’s Privacy Policy and Terms and Conditions. I understand that my consent is not required to purchase, and that cancellation of purchase does not automatically revoke this consent.